Results 31 to 40 of about 10,548 (182)

Changes in eligibility for a subcutaneous cardioverter-defibrillator after implantation of a left ventricular assist device-A prospective analysis.

PLoS ONE, 2023
BackgroundThe number of left ventricular assist devices (LVADs) implanted in patients with end-stage heart failure is increasing. In this patient cohort, subcutaneous implantable cardioverter defibrillators (S-ICDs) could be a promising alternative to ...
Christos Zormpas, Johanna Mueller-Leisse, Stephan Hohmann, Jörg Eiringhaus, Henrike Aenne Katrin Hillmann, Jan D Schmitto, Christian Veltmann, David Duncker   +7 more
doaj   +1 more source

Association between early ventricular arrhythmias and mortality in destination vs. bridge patients on continuous flow LVAD support

Scientific Reports, 2021
The association between ventricular arrhythmias (VAs) and mortality in patients supported by continuous flow left ventricular assist devices (LVAD) remains controversial.
Zeina Jedeon, Rebecca Cogswell, Jessica Schultz, Lisa Von Wald, Ranjit John, Henri Roukoz   +5 more
doaj   +1 more source

Patient-specific, echocardiography compatible flow loop model of aortic valve regurgitation in the setting of a mechanical assist device

Frontiers in Cardiovascular Medicine, 2023
BackgroundAortic regurgitation (AR) occurs commonly in patients with continuous-flow left ventricular assist devices (LVAD). No gold standard is available to assess AR severity in this setting.
Mahwash Kassi, Stefano Filippini, Eleonora Avenatti, Susan Xu, Susan Xu, Kinan Carlos El-Tallawi, Clara I. Angulo, Marija Vukicevic, Marija Vukicevic, Stephen H. Little   +9 more
doaj   +1 more source

Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Type 2 diabetes is prevalent in cardiovascular disease and contributes to excess morbidity and mortality. We sought to investigate the effect of glycemia on functional cardiac improvement, morbidity, and mortality in durable left ventricular ...
Christos P. Kyriakopoulos, Iosif Taleb, Eleni Tseliou, Konstantinos Sideris, Rana Hamouche, Eleni Maneta, Marisca Nelson, Ethan Krauspe, Sean Selko, Joseph R. Visker, Elizabeth Dranow, Matthew L. Goodwin, Rami Alharethi, Omar Wever‐Pinzon, James C. Fang, Josef Stehlik, Craig H. Selzman, Thomas C. Hanff, Stavros G. Drakos   +18 more
doaj   +1 more source

Mechanistic assessment and ablation of left ventricular assist device related ventricular tachycardia in patients with severe heart failure

Frontiers in Physiology, 2023
Aims: Left-ventricular-assist-devices (lvad) are an established treatment for patients with severe heart failure with reduced ejection fraction (HF) and reduce mortality.
Felix Hohendanner, Felix Hohendanner, Felix Hohendanner, Matthias Bock, Julian Keznickl-Pulst, Vesna Furundzija, Vesna Furundzija, Sebastian Scholz, Doreen Schöppenthau, Doreen Schöppenthau, Yuriy Hrytsyna, Yuriy Hrytsyna, Volkmar Falk, Volkmar Falk, Volkmar Falk, Volkmar Falk, Burkert Pieske, Gerhard Hindricks, Gerhard Hindricks, Evgenij Potapov, Evgenij Potapov, Jin-Hong Gerds-Li, Jin-Hong Gerds-Li   +22 more
doaj   +1 more source

HFA of the ESC position paper on the management of LVAD‐supported patients for the non‐LVAD specialist healthcare provider Part 3: at the hospital and discharge

ESC Heart Failure, 2021
The growing population of left ventricular assist device (LVAD)‐supported patients increases the probability of an LVAD‐ supported patient hospitalized in the internal or surgical wards with certain expected device related, and patient‐device interaction
Finn Gustafsson, Binyamin Ben Avraham, Ovidiu Chioncel, Tal Hasin, Avishai Grupper, Aviv Shaul, Sanemn Nalbantgil, Yoav Hammer, Wilfried Mullens, Laurens F. Tops, Jeremy Elliston, Steven Tsui, Davor Milicic, Johann Altenberger, Miriam Abuhazira, Stephan Winnik, Jacob Lavee, Massimo Francesco Piepoli, Lorrena Hill, Righab Hamdan, Arjang Ruhparwar, Stefan Anker, Marisa Generosa Crespo‐Leiro, Andrew J.S. Coats, Gerasimos Filippatos, Marco Metra, Giuseppe Rosano, Petar Seferovic, Frank Ruschitzka, Stamatis Adamopoulos, Yaron Barac, Nicolaas De Jonge, Maria Frigerio, Eva Goncalvesova, Israel Gotsman, Osnat Itzhaki Ben Zadok, Piotr Ponikowski, Luciano Potena, Arsen Ristic, Tiny Jaarsma, Tuvia Ben Gal   +40 more
doaj   +1 more source

Subcutaneous implantable cardioverter‐defibrillator noise following left ventricular assist device implantation

Journal of Arrhythmia, 2023
Background The incidence and impact of noise in a subcutaneous implantable cardioverter defibrillator (S‐ICD) after left ventricular assist device (LVAD) implantation is not well established.
Banveet Kaur Khetarpal, Awad Javaid, Justin Z. Lee, Fred Kusumoto, Siva K. Mulpuru, Dan Sorajja, Yong‐Mei Cha, Komandoor Srivathsan   +7 more
doaj   +1 more source

Incidence and In‐Hospital Mortality of Ventricular Septal Rupture Following Acute Myocardial Infarction

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Ventricular septal rupture (VSR) is a rare but devastating complication of acute myocardial infarction (MI), associated with high mortality despite advances in reperfusion therapy. However, contemporary data examining national trends in VSR outcomes and the evolving role of mechanical circulatory support (MCS) in this population ...
Javier Fernandez, Namra Khan, Muni Rubens, Dorsa Majdpour, Masood Azhar, Mukesh Roy, Anshul Saxena, Sandra Chaparro, Javier Jimenez   +8 more
wiley   +1 more source

Heart phantom with electrical properties of heart muscle tissue

Current Directions in Biomedical Engineering, 2018
The weakened heart is supported by a left ventricular assist device (LVAD) to supply the heart muscle with oxygenated blood. In case the heart muscle recovers during LVAD therapy, the patient has to be weaned from the device.
Korn Leonie, Lyra Simon, Rüschen Daniel, Pugovkin Alexander, Telyshev Dmitry, Leonhardt Steffen, Walter Marian   +6 more
doaj   +1 more source

Socio‐economic inequalities and heart failure morbidity and mortality: A systematic review and data synthesis

ESC Heart Failure, Volume 12, Issue 2, Page 927-941, April 2025.
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor, Willemijn A. van Maarschalkerwaart, Jeroen Schaap, Rudolf A. de Boer, Nicolas M. van Mieghem, Eric H. Boersma, Loek van Heerebeek, Jasper J. Brugts, Robert M.A. van der Boon   +8 more
wiley   +1 more source